© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Messenger RNA vaccines—also called mRNA vaccines—are some of the first COVID-19 vaccines authorized for use in the United States.
Social media posts that make misleading comparisons undermine the science behind the COVID-19 vaccine.
In the United States, an FDA expert advisory panel voted on December 10 to recommend emergency use authorization.
The vaccine from the University of Oxford and AstraZeneca uses a chimpanzee adenovirus vector.
With the first vaccines expected within weeks, a CDC advisory panel votes on how to prioritize access.
Moderna has requested emergency use authorization for its mRNA vaccine candidate.
The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
Upcoming hearing on the Pfizer/BioNTech vaccine will be livestreamed on YouTube, Facebook and Twitter.
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
The World Health Organization coordinates efforts to create flu and COVID-19 vaccines and to fight other global health issues.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.